Related Experiment Video
Updated: Dec 26, 2025

05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
18.2K
Click Chemistry-Based Two-Component System for Efficient Inhibition of Human Immunodeficiency Virus (HIV) Reverse
Carlos E Ledezma1, Evan M Cornett1, Dmitry M Kolpashchikov1
1Department of Chemistry, University of Central Florida, 4111 Libra Drive, Orlando, Florida 32816, United States.
ACS Omega
|March 10, 2020
Summary
New dTTP analogues inhibit human immunodeficiency virus (HIV) reverse transcriptase (RT) by up to 93%. These novel compounds offer a potential basis for developing effective in vivo HIV RT inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- DNA polymerases are crucial enzymes involved in DNA replication and repair.
- Developing targeted inhibitors for enzymes like human immunodeficiency virus (HIV) reverse transcriptase (RT) is vital for antiviral therapies.
- Copper-free click chemistry offers a versatile tool for molecular synthesis and bioconjugation.
Purpose of the Study:
- To synthesize and evaluate novel deoxythymidine triphosphate (dTTP) analogues for copper-free click chemistry.
- To investigate the inhibitory effects of these dTTP analogues on the activity of DNA polymerases, particularly HIV RT.
- To explore the potential of these analogues as a new class of in vivo inhibitors.
Main Methods:
- Synthesis of two specific dTTP analogues designed for copper-free click chemistry.
- In vitro assays to measure the activity of DNA polymerases in the presence of the synthesized analogues.
- Comparative analysis of the inhibitory effects against HIV RT compared to conventional inhibitors like azidothymidine.
Main Results:
- The synthesized dTTP analogues were successfully incorporated into DNA via click chemistry in polymerase active sites.
- Both analogues together suppressed human immunodeficiency virus (HIV) reverse transcriptase (RT) activity by up to 93%.
- The observed inhibition was not overcome by excess primer-template, distinguishing it from azidothymidine's mechanism.
Conclusions:
- Novel dTTP analogues enable copper-free click chemistry within DNA polymerase active sites.
- These analogues demonstrate potent and distinct inhibition of HIV RT activity.
- The findings suggest a promising new avenue for developing effective in vivo inhibitors of HIV RT and other DNA polymerases.

